Elevance Health Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) shares rose 2.67% to $403.04 on Tuesday, outperforming the broader market as the S&P 500 and Dow Jones fell. This gain ended a three-day losing streak for ELV, which remains 7.61% below its 52-week high. While competitors UnitedHealth, Cigna, and Humana also saw gains, Elevance's trading volume was notably lower than its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) advanced 2.67% to $403.04 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.71% to 7,631.47 and Dow Jones Industrial Average falling 0.79% to 52,766.88.
The stock's rise snapped a three-day losing streak.
Elevance Health Inc. closed 7.61% short of its 52-week high of $436.24, which the company reached on July 14th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as UnitedHealth Group Inc. (UNH) rose 1.77% to $396.30, Cigna Group (CI) rose 2.53% to $283.06, and Humana Inc. (HUM) rose 3.04% to $394.88.
Trading volume (959,932) remained 344,640 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-01-26 1641ET